NEUROGENE INC (NGNE)
(Delayed Data from NSDQ)
$21.22 USD
-0.24 (-1.12%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $21.28 +0.06 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NGNE 21.22 -0.24(-1.12%)
Will NGNE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NGNE based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NGNE
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NGNE Stock News
NGNE Crosses Above Key Moving Average Level
Commit To Buy Neurogene At $15, Earn 27.3% Using Options
Analysts Are Bullish on Top Healthcare Stocks: Neurogene (NGNE), Cogent Biosciences (COGT)
12 Health Care Stocks Moving In Friday's After-Market Session